CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 4 filers reported holding CHINA PHARMA HLDGS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | 2,101,626 | $546,000 | 0.40% |
| GLENHILL ADVISORS LLC | 200,000 | $52,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 10,110 | $3,000 | 0.00% |
| Citadel Advisors | 16,114 | $4,000 | 0.00% |
| Renaissance Technologies | 133,600 | $35,000 | 0.00% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 10,000 | $3,000 | 0.00% |
| Virtu KCG Holdings LLC | 27,255 | $7,000 | 0.00% |
| UBS Group AG | 50 | $0 | 0.00% |